Period of time： 2013年5期
Publisher： Future Medicine
Founded in： 2006
Total resources： 64
ISSN： 1746-0794
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Future Virology,volume 4,issue 5
Menu
Good and bad sides of viruses in Type 1 diabetes
By Filippi Christophe M,von Herrath Matthias G in (2009)
Future Virology,volume 4,issue 5 , Vol. 4, Iss. 5, 2009-09 , pp.
Access to resources
Recommend
Systematic approach to the treatment of HCV infection in injection drug users: where are we now?
By Conway Brian,Tossonian Harout K,Raffa Jesse D,Storms Michelle,Duncan Fiona,Grebely Jason in (2009)
Future Virology,volume 4,issue 5 , Vol. 4, Iss. 5, 2009-09 , pp.Towards a broadly active flavivirus therapeutic antibody
By Throsby Mark,de Kruif John in (2009)
Future Virology,volume 4,issue 5 , Vol. 4, Iss. 5, 2009-09 , pp.Update on HIV viral-load assays: new technologies and testing in resource-limited settings
By de Mendoza Carmen,Soriano Vincent in (2009)
Future Virology,volume 4,issue 5 , Vol. 4, Iss. 5, 2009-09 , pp.Chronic hepatitis B and C: update on therapy
By Gonzalez Stevan A,Keeffe Emmet B in (2009)
Future Virology,volume 4,issue 5 , Vol. 4, Iss. 5, 2009-09 , pp.Prospects for future therapy of HCV infection
By Sakamoto Naoya,Wu George Y in (2009)
Future Virology,volume 4,issue 5 , Vol. 4, Iss. 5, 2009-09 , pp.HCV NS2/3 protease: a future antiviral drug target?
By Welbourn Sarah,Pause Arnim in (2009)
Future Virology,volume 4,issue 5 , Vol. 4, Iss. 5, 2009-09 , pp.Origins of membrane vesicles generated during replication of positive-strand RNA viruses
By Cottam Eleanor,Pierini Roberto,Roberts Rebecca,Wileman Thomas in (2009)
Future Virology,volume 4,issue 5 , Vol. 4, Iss. 5, 2009-09 , pp.
Previous
Next